Latest court orders, judgments, and legal developments from Indian courts — AI-curated and summarized.
FeaturedThe Reserve Bank of India has issued the Foreign Exchange Management (Export and Import of Goods and Services) (Amendment) Regulations, 2026, effective September 22, 2026. The amendments update compliance requirements and procedures under FEMA, 1999, for cross-border trade in goods and services.
FeaturedSC permits second Section 28-A application after High Court enhances compensation, citing merger doctrine.
FeaturedSC rules consumer forums can’t forensically reassess surveyor reports absent arbitrariness or service deficiency.
FeaturedDelhi HC sets aside summoning order against director for not examining individual role or specific material.
FeaturedNCLAT confirms ₹437.02 lakh contribution against suspended directors for round-tripping funds and fraudulent property deals under IBC.
FeaturedThe NCLAT clarifies that Section 14 moratorium under IBC protects only the corporate debtor, not its directors, allowing criminal and homebuyer claims to proceed.
FeaturedIPO’s Draft Guidelines for Examination of Pharmaceutical Patent Applications, 2026, face sharp criticism for misquoting statutory provisions and misinterpreting Section 3(d) of the Patents Act. Experts warn the draft could undermine patent stability and prosecution consistency if adopted without revision.
FeaturedThe Supreme Court dismissed SEBI’s appeals and upheld SAT’s interpretation that Regulation 10 of the SEBI (SAST) Regulations applies to combined shareholding of acquirer and promoter/acting in concert (PAC), clarifying the scope of open offer triggers.
FeaturedNew capital adequacy norms require commercial banks to maintain minimum capital for market risk exposures under revised RBI directions.
FeaturedRBI issues multiple amendment directions in 2026 to standardise classification, valuation, and portfolio management for all categories of financial institutions.
FeaturedRBI directs all regulated entities to comply with UAPA, 1967 after designation of a new terrorist organisation under Section 35(1)(a), requiring strict monitoring and reporting.
FeaturedThe Indian Patent Office’s Draft Guidelines for Examination of Pharmaceutical Patent Applications (2026) face strong criticism for misquoting statutory provisions and misinterpreting legal standards. Stakeholders call for substantial revision before finalization.